Metraipolis › archive › dc_e7aa724fa0af

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes — Europe PMC PMID:41410037

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41410037
DOI
10.1161/circulationaha.125.074041
License (as archived)
solo-consultazione
Archived
2026-11-07T13:38:44.072Z
SHA-256 of the archived text
09d6ef560081a9463194ba45335ea4bd2388b1500ee540300b4dc2bda1ddbb4b
Stable URL of this page
https://metraipolis.com/documento/dc_e7aa724fa0af

How to cite

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes — Europe PMC PMID:41410037 — Europe PMC (en), https://europepmc.org/article/MED/41410037 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7aa724fa0af (Metraipolis archive dc_e7aa724fa0af, sha256 09d6ef560081a9463194ba45335ea4bd2388b1500ee540300b4dc2bda1ddbb4b)
BibTeX
@misc{dce7aa724fa0af,
  title = {IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes — Europe PMC PMID:41410037},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41410037},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7aa724fa0af; sha256 09d6ef560081a9463194ba45335ea4bd2388b1500ee540300b4dc2bda1ddbb4b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41410037. Agents can read the archived copy with the MCP tool read_document.